Adding atezolizumab (Tecentriq) to single-agent non–platinum-based chemotherapy and bevacizumab (Avastin) for patients with ...

BMS presented late-stage results on Tuesday at the ASCO annual meeting which showed the combination of Opdivo and Yervoy ...

Topline findings from the phase 2 PICCOLO trial support the potential use of mirvetuximab soravtansine for the treatment of ...

Supported by the Japanese medical service reimbursement system, Herzuma had a 69 percent market share in the Japanese ...

A former sunbed user has warned of their dangers after she spent 15 years battling two bouts of skin cancer. Caroline Madden, 58, cautioned those tempted by tanning booths about the risks posed by ...

In an attempt to treat the serous detachments, ocular treatment was first initiated. Intravitreal 1.25 mg bevacizumab (Avastin, Genentech/Hoffmann-La Roche) was administered OS, and treatment with ...

Stacey Stein, MD, discusses the patient population and outcomes of the IMbrave150 trial of atezolizumab plus bevacizumab for ...

American and European regulatory agencies have provided companies with good news, with several biosimilar candidates seeing application acceptances or approvals in Europe.

CHMP positive opinion is based on a robust analytical, non-clinical and clinical data package comparing Avzivi ® to the reference product Avastin ® Cautionary Note Regarding Forward-Looking Statements ...

Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks ...